Oracle Films | 4 March In October 2020 Dr Andrew Hill was tasked to report to the World Health Organisation on the dozens of new studies from around the world suggesting that Ivermectin could be a remarkably safe and effective treatment for COVID-19. But on January 18th 2021, Dr Hill published his findings on a…
Steve Kirsch | 23 Feb 2022 Whoops! How embarrassing! The CDC gave you bad advice. If you want to survive COVID, you should use the drug they said to avoid, and avoid the drug they said to use. Remember that “horse dewormer” that the FDA, CDC, NIH, CNN, and Sanjay Gupta all told you not…
Mercola | 16 Feb 2022 Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding ivermectin outperformed all of them, including nirmatrelvir (Paxlovid), a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment. Story at-a-glance: Researchers used computational analyses to evaluate…
Pierre Kory | 20 Feb 2022 Big Pharma influences high-impact journals to selectively publish (purportedly) negative studies while outright rejecting positive studies from publication. JAMA did it again yesterday. One of the main corporate disinformation tactics used to suppress “science that is inconvenient to their interests” is to employ what is called the “Diversion,” defined…
FLCCC Alliance | 20 Feb 2020 FLCCC Doctors: “We treat patients, not p-values.” JAMA has done it again. “It” is the February 18, 2022 publication of a study on ivermectin with a conclusion that inexplicably departs from the study’s own data. Even worse, the Malaysian I-TECH Randomized Clinical Trial and JAMA itself dismiss the totality…
Jessica Rose | 20 Feb 2020 Follow-up on paper in last post… There’s a big ‘debate’ about off-label drugs being used as treatments for COVID-19. If one wishes to determine whether or not a drug ‘works’ or not, one might compare the frequency of ‘bad’ outcomes in treated versus non-treated groups.1 I published a Substack article yesterday and…
Jessica Rose | 19 Feb 2022 There’s a new paper in town entitled: “Efficacy of 1טeרmEזכiה Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesThe I-TECH Randomized Clinical Trial”. It was published today: February 18, 2022 – the darkest day that my beautiful Canada has EVER faced. I love you my…
Research Gate | Dec 2021 Background: Ivermectin has demonstrated different mechanisms of actions that could potentially protect from both COVID-19 infection and COVID-19-related comorbidities. Based on the existing literature and safety profile of ivermectin, a citywide program of prophylactic use of ivermectin for COVID-19 was implemented in Itajai, a Southern city in Brazil in the…
Indian Express | 12 May 2021 Claiming that timely introduction of Ivermectin since the first wave has helped the state maintain a relatively low positivity rate despite in its high population density. A year after the country’s first Covid-19 cluster, with 5 cases, was reported in Agra district, the Uttar Pradesh government has claimed that it was…